Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: A SEER analysis

Gynecologic Oncology

Volumn 131, Issue 2, 2013, Pages 404-409

  Rauh Hain, J Alejandro ^a   Davis, Michelle ^a   Clemmer, Joel ^a   Clark, Rachel M ^a   Growdon, Whitfield B ^a   Goodman, A K ^a   Boruta II, David M ^a   Schorge, John O ^a   Del Carmen, Marcela G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Ovarian clear cell carcinoma; Uterine clear cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; ENDOMETRIUM CANCER; FEMALE; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NEOPLASM; OVARIAN CLEAR CELL CARCINOMA; OVARY CARCINOMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; TREATMENT OUTCOME; UTERUS; UTERUS CARCINOMA;

OVARIAN CLEAR CELL CARCINOMA; UTERINE CLEAR CELL CARCINOMA;

ADENOCARCINOMA, CLEAR CELL; AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SEER PROGRAM; UNITED STATES; UTERINE NEOPLASMS;

EID: 84886090302     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.08.029     Document Type: Article

References (22)

1. J.A. Rauh Hain, D. Winograd, W.B. Growdon, J.O. Schorge, A.K. Goodman, and D.M. Boruta Prognostic determinants in patients with uterine and ovarian clear carcinoma Gynecol Oncol 125 2 2012 376 380
2. K.K. Zorn, T. Bonome, L. Gangli, G.V. Chandramouli, C.S. Awtrey, and G.J. Gardner Gene expression profiles of serous, endometroid and clear cell subtypes of ovarian and endometrial cancer Clin Res 11 2005 6422 6430
3. M. Fujita, T. Enomoto, and Y. Murata Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes Mol Cell Endocrinol 202 2003 97 99
4. S.F. Serov, R.E. Scully, and L.H. Sobin International histological classification of tumors, number 9 Histologic typing of ovarian tumors 1973 World Health Organization Geneva 1 7
5. A.W. Kennedy, C.V. Biscotti, W.R. Hart, and K.D. Webester Ovarian clear cell adenocarcinoma Gynecol Oncol 32 1989 342 349
6. G.A. Omura, M.F. Brady, H.D. Homesley, E. Yordan, F.J. Major, and H.J. Buchsbaum Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience J Clin Oncol 9 1991 1138 1150
7. M.E. O'Brien, J.B. Schofield, S. Tan, I. Fryatt, C. Fisher, and E. Wiltshaw Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages Gynecol Oncol 49 1993 250 254
8. K. Behbakht, T.C. Randall, I. Benjamin, M.A. Morgan, S. King, and S.C. Rubin Clinical characteristics of clear cell carcinoma of the ovary Gynecol Oncol 70 1998 255 258
9. J.A. Rauh-Hain, I. Costaaggini, A.B. Olawaiye, W.B. Growdon, N.S. Horowits, and M.G. del Carmen A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy Eur J Gynaecol Oncol 31 3 2010 284 287
10. V.M. Abeler, and K.E. Kjorstad Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases Gynecol Oncol 40 1991 207 217
11. V.M. Abeler, I.B. Vergote, K.E. Kjorstad, and C.G. Trope Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern Cancer 78 1996 1740 1747
12. O. Fadare, S.X. Liang, E.C. Ulukus, S.K. Chambers, and W. Zheng Precursors of endometrial clear cell carcinoma Am J Surg Pathol 30 12 2006 1519 1530
13. N. Sakuragi, H. Hareyama, Y. Todo, H. Yamada, R. Yamamoto, and T. Fujino Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma Acta Obstet Gynecol Scand 79 4 2000 311 316
14. A.B. Olawaiye, and D.M. Boruta II Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review Gynecol Oncol 113 2 2009 277 283
15. M. Thomas, A. Mariani, J.D. Wright, E.O. Madarek, M.A. Powell, and D.G. Mutch Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review Gynecol Oncol 108 2 2008 293 297
16. J. Cirisano, D. Frank, S.J. Robboy, R.K. Dodge, R.C. Bentley, and H.R. Krigman Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma Gynecol Oncol 74 3 1999 385 394
17. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1988-2009), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission.
18. J.K. Chan, D. Teoh, J.M. Hu, J.Y. Shin, K. Osann, and D.S. Kapp Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers Gynecol Oncol 109 2008 370 376
19. T. Sugiyama, T. Kamura, J. Kigawa, N. Terakawa, Y. Kikuchi, and T. Kita Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy Cancer 88 2000 2584 2589
20. J.D. Wright, J. Fiorelli, P.B. Schiff, W.M. Burke, A.L. Kansler, and C.J. Cohen Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time Cancer 115 6 Mar 15 2009 1276 1285
21. M.A. Crozier, L.J. Copeland, E.G. Silva, D.M. Gershenson, and C.A. Stringer Clear cell carcinoma of the ovary: a study of 59 cases Gynecol Oncol 35 1989 199 203
22. D. Pectasides, G. Fountzilas, G. Aravantinos, C. Kalofonos, H. Efstathiou, and D. Farmakis Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience Gynecol Oncol 102 2 2006 285 291